Age 0 3 0 3 B-age
â‰¥18 4 7 4 7 O
years 8 13 8 13 I-lower_bound
and 14 17 14 17 O
< 18 19 18 19 O
75 20 22 20 22 B-upper_bound

Participants 0 12 23 35 O
must 13 17 36 40 O
be 18 20 41 43 O
candidates 21 31 44 54 O
for 32 35 55 58 O
definitive 36 46 59 69 B-treatment
local 47 52 70 75 I-treatment
therapy 53 60 76 83 I-treatment
with 61 65 84 88 I-treatment
breast 66 72 89 95 I-treatment
conserving 73 83 96 106 I-treatment
therapy 84 91 107 114 I-treatment
( 92 93 115 116 O
this 93 97 116 120 O
takes 98 103 121 126 O
into 104 108 127 131 O
account 109 116 132 139 O
tumor 117 122 140 145 B-cancer
to 123 125 146 148 O
breast 126 132 149 155 O
size 133 137 156 160 O
ratio 138 143 161 166 O
appropriate 144 155 167 178 O
for 156 159 179 182 O
BCS 160 163 183 186 B-treatment
, 163 164 186 187 O
and 165 168 188 191 O
the 169 172 192 195 O
ability 173 180 196 203 O
to 181 183 204 206 O
undergo 184 191 207 214 O
standard 192 200 215 223 B-treatment
radiation 201 210 224 233 I-treatment
therapy 211 218 234 241 I-treatment
post 219 223 242 246 O
- 223 224 246 247 O
operatively 224 235 247 258 O
) 235 236 258 259 O

Participants 0 12 260 272 O
must 13 17 273 277 O
have 18 22 278 282 O
biopsy 23 29 283 289 B-treatment
confirmed 30 39 290 299 O
and 40 43 300 303 O
clinical 44 52 304 312 O
stage 53 58 313 318 B-lower_bound
1 59 60 319 320 I-lower_bound
or 61 63 321 323 O
stage 64 69 324 329 B-upper_bound
2 70 71 330 331 I-upper_bound
breast 72 78 332 338 B-cancer
carcinoma 79 88 339 348 I-cancer

Participants 0 12 349 361 O
who 13 16 362 365 O
are 17 20 366 369 B-pregnancy
pregnant 21 29 370 378 I-pregnancy

Participants 0 12 379 391 O
who 13 16 392 395 O
enroll 17 23 396 402 O
in 24 26 403 405 O
a 27 28 406 407 O
preoperative 29 41 408 420 B-treatment
therapy 42 49 421 428 I-treatment
trial 50 55 429 434 O
or 56 58 435 437 O
who 59 62 438 441 O
have 63 67 442 446 O
been 68 72 447 451 O
treated 73 80 452 459 O
with 81 85 460 464 O
neoadjuvant 86 97 465 476 B-treatment
chemotherapy 98 110 477 489 I-treatment

Participants 0 12 490 502 O
who 13 16 503 506 O
exceed 17 23 507 513 O
the 24 27 514 517 O
weight 28 34 518 524 B-clinical_variable
limit 35 40 525 530 O
for 41 44 531 534 O
the 45 48 535 538 O
surgical 49 57 539 547 O
table 58 63 548 553 O
at 64 66 554 556 O
AMIGO 67 72 557 562 O
, 72 73 562 563 O
350 74 77 564 567 B-lower_bound
lbs 78 81 568 571 I-lower_bound
or 82 84 572 574 O
who 85 88 575 578 O
will 89 93 579 583 O
not 94 97 584 587 O
fit 98 101 588 591 O
into 102 106 592 596 O
the 107 110 597 600 O
70 111 113 601 603 B-lower_bound
cm 114 116 604 606 I-lower_bound
diameter 117 125 607 615 I-lower_bound
bore 126 130 616 620 O
of 131 133 621 623 O
the 134 137 624 627 O
MRI 138 141 628 631 O
scanner 142 149 632 639 O
at 150 152 640 642 O
AMIGO 153 158 643 648 O
or 159 161 649 651 O
the 162 165 652 655 O
60 166 168 656 658 B-lower_bound
cm 169 171 659 661 I-lower_bound
diameter 172 180 662 670 I-lower_bound
bore 181 185 671 675 O
of 186 188 676 678 O
the 189 192 679 682 O
pre 193 196 683 686 O
- 196 197 686 687 O
procedure 197 206 687 696 O
imaging 207 214 697 704 O
MRI 215 218 705 708 O
scanner 219 226 709 716 O

Participants 0 12 717 729 O
who 13 16 730 733 O
have 17 21 734 738 O
documented 22 32 739 749 O
contra 33 39 750 756 O
- 39 40 756 757 O
indications 40 51 757 768 O
for 52 55 769 772 O
contrast 56 64 773 781 B-treatment
- 64 65 781 782 I-treatment
enhanced 65 73 782 790 I-treatment
MRI 74 77 791 794 I-treatment
, 77 78 794 795 O
including 79 88 796 805 O
but 89 92 806 809 O
not 93 96 810 813 O
limited 97 104 814 821 O
to 105 107 822 824 O
renal 108 113 825 830 B-chronic_disease
failure 114 121 831 838 I-chronic_disease

Participants 0 12 839 851 O
with 13 17 852 856 O
known 18 23 857 862 O
Li 24 26 863 865 B-cancer
- 26 27 865 866 I-cancer
Fraumeni 27 35 866 874 I-cancer
or 36 38 875 877 O
Cowden 39 45 878 884 B-cancer
's 45 47 884 886 I-cancer
Disease 48 55 887 894 I-cancer

Participants 0 12 895 907 O
with 13 17 908 912 O
known 18 23 913 918 O
active 24 30 919 925 O
collagen 31 39 926 934 B-chronic_disease
vascular 40 48 935 943 I-chronic_disease
disease 49 56 944 951 I-chronic_disease

Participants 0 12 952 964 O
with 13 17 965 969 O
locally 18 25 970 977 O
advanced 26 34 978 986 O
breast 35 41 987 993 B-cancer
cancer 42 48 994 1000 I-cancer
such 49 53 1001 1005 O
as 54 56 1006 1008 O
inflammatory 57 69 1009 1021 O
breast 70 76 1022 1028 O
cancer 77 83 1029 1035 O
or 84 86 1036 1038 O
cancer 87 93 1039 1045 O
grossly 94 101 1046 1053 O
involving 102 111 1054 1063 O
skin 112 116 1064 1068 O

Participants 0 12 1069 1081 O
with 13 17 1082 1086 O
prior 18 23 1087 1092 O
history 24 31 1093 1100 O
of 32 34 1101 1103 O
ipsilateral 35 46 1104 1115 B-cancer
breast 47 53 1116 1122 I-cancer
carcinoma 54 63 1123 1132 I-cancer

Participants 0 12 1133 1145 O
with 13 17 1146 1150 O
prior 18 23 1151 1156 B-treatment
mantle 24 30 1157 1163 I-treatment
radiation 31 40 1164 1173 I-treatment

Patient 0 7 1174 1181 O
must 8 12 1182 1186 O
meet 13 17 1187 1191 O
standard 18 26 1192 1200 O
MRI 27 30 1201 1204 B-treatment
guidelines 31 41 1205 1215 O
and 42 45 1216 1219 O
be 46 48 1220 1222 O
able 49 53 1223 1227 O
and 54 57 1228 1231 O
willing 58 65 1232 1239 O
to 66 68 1240 1242 O
undergo 69 76 1243 1250 O
MRI 77 80 1251 1254 O

Patients 0 8 1255 1263 O
must 9 13 1264 1268 O
be 14 16 1269 1271 O
female 17 23 1272 1278 B-gender

Patients 0 8 1279 1287 O
who 9 12 1288 1291 O
have 13 17 1292 1296 O
biopsy 18 24 1297 1303 B-treatment
confirmed 25 34 1304 1313 O
multi 35 40 1314 1319 B-cancer
- 40 41 1319 1320 I-cancer
centric 41 48 1320 1327 I-cancer
disease 49 56 1328 1335 I-cancer

